Monika Schoels
About
Monika Schoels is a scholar working on Rheumatology, Immunology and Genetics.
According to data from OpenAlex, Monika Schoels has authored 22 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 9 papers in Immunology and 6 papers in Genetics. Recurrent topics in Monika Schoels's work include Rheumatoid Arthritis Research and Therapies (17 papers), Spondyloarthritis Studies and Treatments (8 papers) and Systemic Lupus Erythematosus Research (7 papers). Monika Schoels is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (17 papers), Spondyloarthritis Studies and Treatments (8 papers) and Systemic Lupus Erythematosus Research (7 papers). Monika Schoels collaborates with scholars based in Austria, United States and Germany. Monika Schoels's co-authors include Josef S Smolen, Daniel Aletaha, Farideh Alasti, Paul Emery, Désirée van der Heijde, Ferdinand C. Breedveld, Tore K Kvien, John B. Wong, Josef S Smolen and Thomas Dörner and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.
In The Last Decade
Monika Schoels
22 papers receiving 1.7k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Monika Schoels Austria | 15 | 1.5k | 706 | 661 | 230 | 225 | 22 | 1.8k | ||
| Bonnie Vlahos United States | 23 | 1.5k 1.0× | 752 1.1× | 553 0.8× | 209 0.9× | 115 0.5× | 62 | 1.8k | ||
| John Han United States | 17 | 1.9k 1.2× | 754 1.1× | 831 1.3× | 261 1.1× | 154 0.7× | 20 | 2.3k | ||
| J.H.L.M. van Groenendael Netherlands | 16 | 1.9k 1.2× | 324 0.5× | 744 1.1× | 406 1.8× | 282 1.3× | 22 | 2.1k | ||
| J-C Becker United States | 13 | 1.7k 1.1× | 484 0.7× | 745 1.1× | 431 1.9× | 365 1.6× | 17 | 2.1k | ||
| M. Lange United States | 6 | 1.7k 1.1× | 574 0.8× | 941 1.4× | 277 1.2× | 234 1.0× | 7 | 2.2k | ||
| K. H. Han Netherlands | 10 | 1.6k 1.0× | 243 0.3× | 633 1.0× | 355 1.5× | 252 1.1× | 16 | 1.8k | ||
| Y P M Goekoop-Ruiterman Netherlands | 20 | 2.4k 1.5× | 399 0.6× | 880 1.3× | 485 2.1× | 348 1.5× | 30 | 2.6k | ||
| F. Navarro-Sarabia Spain | 16 | 933 0.6× | 327 0.5× | 367 0.6× | 164 0.7× | 92 0.4× | 27 | 1.1k | ||
| Piotr Leszczyński Poland | 20 | 914 0.6× | 813 1.2× | 269 0.4× | 108 0.5× | 121 0.5× | 70 | 1.5k | ||
| Anders Gülfe Sweden | 13 | 829 0.5× | 387 0.5× | 283 0.4× | 116 0.5× | 103 0.5× | 21 | 1.1k |
Countries citing papers authored by Monika Schoels
Since
Specialization
Citations
This map shows the geographic impact of Monika Schoels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Schoels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Schoels more than expected).
Fields of papers citing papers by Monika Schoels
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Monika Schoels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Schoels. The network helps show where Monika Schoels may publish in the future.
Co-authorship network of co-authors of Monika Schoels
This figure shows the co-authorship network connecting the top 25 collaborators of Monika Schoels. A scholar is included among the top collaborators of Monika Schoels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Schoels. Monika Schoels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Schoels, Monika, et al.. (2018). Early response to therapy predicts 6-month and 1-year disease activity outcomes in psoriatic arthritis patients. Lara D. Veeken. 57(6). 969–976.
2.
Leuchten, Nicolai, Annika Hoyer, Ralph Brinks, et al.. (2017). Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta‐Regression of Diagnostic Data. Arthritis Care & Research. 70(3). 428–438.
3.
Schoels, Monika, Farideh Alasti, Josef S Smolen, & Daniel Aletaha. (2017). Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition. Arthritis Research & Therapy. 19(1). 155–155.
4.
Kay, Jonathan, Monika Schoels, Thomas Dörner, et al.. (2017). Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases. Annals of the Rheumatic Diseases. 77(2). 165–174.
5.
Stoffer, Michaela, Monika Schoels, Josef S Smolen, et al.. (2015). Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Annals of the Rheumatic Diseases. 75(1). 16–22.
6.
Schoels, Monika, Daniel Aletaha, Farideh Alasti, & Josef S Smolen. (2015). Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Annals of the Rheumatic Diseases. 75(5). 811–818.
7.
Leuchten, Nicolai, Ralph Brinks, Annika Hoyer, et al.. (2015). SAT0415 Performance of Anti-Nuclear Antibodies (ANA) for Classifying Systemic Lupus Erythematosus (SLE): A Systematic Literature Review and Meta-Regression of Diagnostic Data. Annals of the Rheumatic Diseases. 74. 809–810.
8.
Bykerk, Vivian P. & Monika Schoels. (2013). Treatment strategies for early rheumatoid arthritis. Current Opinion in Rheumatology. 25(3). 375–383.
9.
Schoels, Monika, Jürgen Braun, Maxime Dougados, et al.. (2013). Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Annals of the Rheumatic Diseases. 73(1). 238–242.
10.
Smolen, Josef S, Maxime Dougados, Paul Emery, et al.. (2013). OP0110 Treat-To-Target Recommendations for Spondyloarthritis, Including Ankylosing Spondylitis and Psoriatic Arthritis: A Consensus of an International Task Force. Annals of the Rheumatic Diseases. 72. A88–A89.
11.
Schoels, Monika, Désirée van der Heijde, Ferdinand C. Breedveld, et al.. (2012). Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement. Annals of the Rheumatic Diseases. 72(4). 583–589.
12.
Schoels, Monika, Daniel Aletaha, Josef S Smolen, & John B. Wong. (2012). Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis. Annals of the Rheumatic Diseases. 71(8). 1303–1308.
13.
Schoels, Monika & Josef S Smolen. (2012). Treating rheumatoid arthritis to target: Evidence-based recommendations for enhanced disease management. Reumatología Clínica (English Edition). 8(1). 1–2.
14.
Schoels, Monika, Daniel Aletaha, J. W. J. Bijlsma, et al.. (2010). Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Annals of the Rheumatic Diseases. 69(4). 638–643.
15.
Knevel, Rachel, Monika Schoels, T. Huizinga, et al.. (2010). Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 69(6). 987–994.
16.
Schoels, Monika, John B. Wong, David L. Scott, et al.. (2010). Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 69(6). 995–1003.
17.
Schoels, Monika, Daniel Aletaha, Josef S Smolen, et al.. (2009). Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008. Annals of the Rheumatic Diseases. 69(3). 575–578.
18.
Schoels, Monika, et al.. (2007). Assessing remission in clinical practice. Lara D. Veeken. 46(6). 975–979.
19.
Schoels, Monika, Theresa Kapral, Tanja Stamm, J S Smolen, & Daniel Aletaha. (2007). Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study. Annals of the Rheumatic Diseases. 66(8). 1059–1065.
20.
Kapral, Theresa, Klaus Machold, Tanja Stamm, et al.. (2007). Remission by composite scores in rheumatoid arthritis: are ankles and feet important?. Arthritis Research & Therapy. 9(4). R72–R72.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bonnie Vlahos Breakdown of academic impact, for papers by John Han Breakdown of academic impact, for papers by J.H.L.M. van Groenendael Breakdown of academic impact, for papers by J-C Becker Breakdown of academic impact, for papers by M. Lange Breakdown of academic impact, for papers by K. H. Han Breakdown of academic impact, for papers by Y P M Goekoop-Ruiterman Breakdown of academic impact, for papers by F. Navarro-Sarabia Breakdown of academic impact, for papers by Piotr Leszczyński Breakdown of academic impact, for papers by Anders Gülfe